Sanofi (SNW)
TG
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 36.53B | 35.07B | 34.46B | 36.13B | 36.04B | 37.76B | 43B | 43.07B |
Operating Income | 7.21B | 12.23B | 4.75B | 3.13B | 6.42B | 7.71B | 10B | 7.19B |
Pre Tax Income | 6.35B | 11.87B | 4.39B | 2.82B | 13.78B | 7.8B | 10.42B | 7.15B |
Net Income | 4.71B | 8.42B | 4.31B | 2.81B | 12.29B | 6.22B | 8.37B | 5.4B |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 3.645 | 6.711 | 3.452 | 2.238 | 9.765 | 4.925 | 6.639 | 4.269 |
EBIT | 7.21B | 12.23B | 4.75B | 3.13B | 6.73B | 8.13B | 10.66B | 7.88B |
EBITDA | 10.53B | 15.91B | 9.02B | 10.57B | 10.06B | 11.06B | 13.41B | 11.97B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.